* Methotrexate MYLAN 50 mg/2 mL ((25MG/ML) 10 vials of 2 mL, solution for injection.
& intravenous (IV), intramuscular (IM), subcutaneous (SC), intra-arterial, intrathecal use.
* It is also effective antirheumatoid.
* Composition: Methotrexate 50 mg per 2 ml of solution for injection.
* List of excipients:
– Excipients that cause well-known effects: sodium (sodium chloride and sodium hydroxide).
– Other excipient: water for injections.
* Method and route of administration: Parenteral use.
* Special warnings: Read the leaflet carefully before use.
* Special storage conditions:
– To be stored at a temperature not exceeding 25 degrees C.
– To be stored in the outer packaging, protected from light.
* After dilution:
It is recommended that the preparation should be used immediately. However, it has been shown to be stable for 12 hours at a temperature of 25 degrees C in 0.9% isotonic sodium chloride or 5% isotonic glucose solutions. Other in-use storage times and conditions are the responsibility of the user.
* Special precautions for disposing of unused drugs or waste derived from such drugs, where applicable:
The handling of this cytotoxic drug by nursing or medical personnel requires that all precautions should be taken to ensure the protection of the manipulator and his/her environment (“see Leaflet: How to take Methotrexate MYLAN 50 mg/2 ml, solution for injection?”).
المراجعات
لا توجد مراجعات بعد.